{
    "code": "52026942",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026942",
    "time": "2018-01-05 03:28:57",
    "許可證字號": "衛部藥輸字第026942號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "110\/11\/18",
    "發證日期": "105\/11\/18",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202694202",
    "中文品名": "善妥達持續性藥效肌肉注射懸浮劑",
    "英文品名": "Invega Trinza Prolonged-Release Suspension for Injection",
    "適應症": "INVEGA TRINZA (paliperidone palmitate)是一種3個月型注射劑，用於已使用INVEGA\r\nSUSTENNA® (1個月型paliperidone palmitate 持續性藥效注射用懸浮液)充分治療至少4 個月後之思覺失調症患者。",
    "劑型": "27B持續性藥效肌肉注射用懸浮液",
    "包裝": "0.875毫升、1.315毫升、1.75毫升及2.625毫升注射針筒裝附2支安全針頭",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "PALIPERIDONEPALMITATE"
    ],
    "限制項目": "02輸　入 26監視期滿新藥",
    "申請商名稱": "1507401100  嬌生股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F050082100  JANSSEN PHARMACEUTICA N.V.",
        "製造廠廠址": "TURNHOUTSEWEG 30, 2340, BEERSE, BELGIUM",
        "製造廠公司地址": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "6605071926  久裕企業股份有限公司",
            "製造廠廠址": "桃園市桃園區大林里興邦路43巷2之1號4樓，3樓B區，1樓A區",
            "製造廠公司地址": "",
            "製造廠國別": "",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2816100710",
            "成分名稱": "PALIPERIDONE PALMITATE",
            "含量描述": "(equivalent to 200 mg\/ml paliperidone)",
            "含量": "312.0000000000",
            "單位": "MG\/ML"
        }
    ],
    "仿單外盒": [
        {
            "title": "附件2_0811-PI_Invega Trinza_USPI Mar2016_v1601_62x54cm Hi-106-09-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026942&Seq=002&Type=9"
        }
    ]
}